These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36571200)

  • 21. In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663).
    Chauret N; Yergey JA; Brideau C; Friesen RW; Mancini J; Riendeau D; Silva J; Styhler A; Trimble LA; Nicoll-Griffith DA
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1059-62. PubMed ID: 11327589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis.
    Takahashi T; Zhu SJ; Sumino H; Saegusa S; Nakahashi T; Iwai K; Morimoto S; Kanda T
    Life Sci; 2005 Nov; 78(2):195-204. PubMed ID: 16107267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2.
    Papanicolaou KN; Streicher JM; Ishikawa TO; Herschman H; Wang Y; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):196-209. PubMed ID: 20399788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences.
    Tintu A; Rouwet E; Verlohren S; Brinkmann J; Ahmad S; Crispi F; van Bilsen M; Carmeliet P; Staff AC; Tjwa M; Cetin I; Gratacos E; Hernandez-Andrade E; Hofstra L; Jacobs M; Lamers WH; Morano I; Safak E; Ahmed A; le Noble F
    PLoS One; 2009; 4(4):e5155. PubMed ID: 19357774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-proliferative and apoptotic effects of etoricoxib, a selective COX-2 inhibitor, on 1,2-dimethylhydrazine dihydrochloride-induced colon carcinogenesis.
    Tanwar L; Piplani H; Sanyal S
    Asian Pac J Cancer Prev; 2010; 11(5):1329-33. PubMed ID: 21198287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancer.
    Nadda N; Vaish V; Setia S; Sanyal SN
    Biomed Pharmacother; 2012 Sep; 66(6):474-83. PubMed ID: 22681911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy.
    Dragani A; Pascale S; Recchiuti A; Mattoscio D; Lattanzio S; Petrucci G; Mucci L; Ferrante E; Habib A; Ranelletti FO; Ciabattoni G; Davì G; Patrono C; Rocca B
    Blood; 2010 Feb; 115(5):1054-61. PubMed ID: 19887674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats.
    Citraro R; Leo A; Marra R; De Sarro G; Russo E
    Brain Res Bull; 2015 Apr; 113():1-7. PubMed ID: 25701797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the Highly COX-2-Selective Analgesic NSAID Etoricoxib on Human Periodontal Ligament Fibroblasts during Compressive Orthodontic Mechanical Strain.
    Kirschneck C; Küchler EC; Wolf M; Spanier G; Proff P; Schröder A
    Mediators Inflamm; 2019; 2019():2514956. PubMed ID: 30983880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of myocardial Gata4 and Tbx5 results in defects in cardiomyocyte proliferation and atrioventricular septation.
    Misra C; Chang SW; Basu M; Huang N; Garg V
    Hum Mol Genet; 2014 Oct; 23(19):5025-35. PubMed ID: 24858909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis.
    Setia S; Sanyal SN
    Pharmacol Rep; 2012; 64(3):615-24. PubMed ID: 22814015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticonvulsant activity of the cyclooxygenase-2 (COX-2) inhibitor etoricoxib in pentylenetetrazole-kindled rats is associated with memory impairment.
    Katyal J; Kumar H; Gupta YK
    Epilepsy Behav; 2015 Mar; 44():98-103. PubMed ID: 25660085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of etoricoxib, a novel, selective COX-2 inhibitor.
    Dallob A; Hawkey CJ; Greenberg H; Wight N; De Schepper P; Waldman S; Wong P; DeTora L; Gertz B; Agrawal N; Wagner J; Gottesdiener K
    J Clin Pharmacol; 2003 Jun; 43(6):573-85. PubMed ID: 12817520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with paracetamol, ketorolac or etoricoxib did not hinder alveolar bone healing: a histometric study in rats.
    Fracon RN; Teófilo JM; Moris IC; Lamano T
    J Appl Oral Sci; 2010 Dec; 18(6):630-4. PubMed ID: 21308296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota-derived endotoxin enhanced the incidence of cardia bifida during cardiogenesis.
    Zhang J; Wang G; Liu J; Gao LR; Liu M; Wang CJ; Chuai M; Bao Y; Li G; Li RM; Zhang Y; Yang X
    J Cell Physiol; 2018 Dec; 233(12):9271-9283. PubMed ID: 28885685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Etoricoxib on Hepatic Ischemia-Reperfusion Injury in Rats.
    Kunak CS; Kukula O; Mutlu E; Genç F; Peker GG; Kuyrukluyıldız U; Binici O; Altuner D; Alp HH
    Oxid Med Cell Longev; 2015; 2015():598162. PubMed ID: 26236425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMAD-mediated modulation of YY1 activity regulates the BMP response and cardiac-specific expression of a GATA4/5/6-dependent chick Nkx2.5 enhancer.
    Lee KH; Evans S; Ruan TY; Lassar AB
    Development; 2004 Oct; 131(19):4709-23. PubMed ID: 15329343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development.
    Maitra M; Schluterman MK; Nichols HA; Richardson JA; Lo CW; Srivastava D; Garg V
    Dev Biol; 2009 Feb; 326(2):368-77. PubMed ID: 19084512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of NF-κB and PCNA in the regulatory pathways of apoptosis by cyclooxygenase-2 inhibitors in experimental lung cancer.
    Setia S; Sanyal SN
    Mol Cell Biochem; 2012 Oct; 369(1-2):75-86. PubMed ID: 22752388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cyclooxygenase-2 inhibitor etoricoxib is a potent chemopreventive agent of colon carcinogenesis in the rat model.
    Saini MK; Sharma P; Kaur J; Sanyal SN
    J Environ Pathol Toxicol Oncol; 2009; 28(1):39-46. PubMed ID: 19392653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.